A ‘slight’ delay in commercial Rollout of Sputnik-V vaccine, says Dr Reddy’s

The delay is “due to dependency on imported consignments, and quality testing in India”, the company has said.

Recently today, Dr. Reddy  said there is a “slight postponement” in the timeline of the commercial launch of Sputnik V coronavirus vaccine due to dependency on imported consignments, and quality testing in India, a statement that has implications for India’s vaccination drive.

One of the spokesperson from the company said on June 29 that, “Our cold storage and other logistical arrangements are being executed in line with our commercialization plan and are on track with no issues.”

The delay comes at a time when India is looking to step up the vaccine drive to vaccinate all eligible people by the end of 2021. The Russian-made Sputnik vaccine, is to be manufactured in India by Dr Reddy and a few other Indian pharma firms, in integral to meeting the ambitious target.

As per the earlier reports around three million doses of Sputnik have arrived in India and the batch of second dose is likely to land in India by the end of June.

The company has said that it is updating as per government authorities, media and members of the public on a regular basis. Sputnik V is priced at Rs 995 per dose including GST.

The statement said that, “This pilot phase has allowed us to test our cold storage arrangements of -18 degree C temperature in these cities, CoWIN integration, track-and-trace and other logistical arrangements ahead of our commercial launch.”

It also added that, adequate numbers of cold chain units were being deployed, and the last-mile cold chain arrangement was being validated at every partner hospital to ensure seamless storage and handling of the vaccine.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More